CRSP earnings: a negative outcome, -5.1%

On August 7, 2023, CRISPR Therapeutics AG reached its earnings. The result was a negative outcome, and the stock moved -5.1% in the window around the event. It had already run -6.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.